Order Article Reprints

Bidar F, Bodinier M, Venet F, Lukaszewicz A-C, Brengel-Pesce K, Conti F, Quemeneur L, Leissner P, Tan LK, Textoris J, et al. Concomitant Assessment of Monocyte HLA-DR Expression and Ex Vivo TNF-α Release as Markers of Adverse Outcome after Various Injuries—Insights from the REALISM Study. Journal of Clinical Medicine. 2022; 11(1):96. https://doi.org/10.3390/jcm11010096

Bidar, Frank, Maxime Bodinier, Fabienne Venet, Anne-Claire Lukaszewicz, Karen Brengel-Pesce, Filippo Conti, Laurence Quemeneur, Philippe Leissner, Lionel K. Tan, Julien Textoris, and et al. 2022. "Concomitant Assessment of Monocyte HLA-DR Expression and Ex Vivo TNF-α Release as Markers of Adverse Outcome after Various Injuries—Insights from the REALISM Study" Journal of Clinical Medicine 11, no. 1: 96. https://doi.org/10.3390/jcm11010096

Bidar, F., Bodinier, M., Venet, F., Lukaszewicz, A.-C., Brengel-Pesce, K., Conti, F., Quemeneur, L., Leissner, P., Tan, L. K., Textoris, J., Rimmelé, T., Monneret, G., & on behalf of the Realism Study Group. (2022). Concomitant Assessment of Monocyte HLA-DR Expression and Ex Vivo TNF-α Release as Markers of Adverse Outcome after Various Injuries—Insights from the REALISM Study. Journal of Clinical Medicine, 11(1), 96. https://doi.org/10.3390/jcm11010096